LUTHERVILLE, Md., July 20, 2015 (GLOBE NEWSWIRE) -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion lauded the latest National Precursor Log Exchange (NPLEx) results. NPLEx reported results for January through June 2015 for the real-time, stop-sale system.
The breakdown by state in the report shows the total number of boxes reported as purchased, the total number of grams reported as purchased, the total number of boxes and grams that were blocked based on state and federal laws, and the total number of unique individuals reported as purchasing over-the-counter PSE/EPH. These numbers indicate the laws that are being enforced by NPLEx at the point-of-sale, in real-time, and across state lines.
NADDI Executive Director Charles Cichon said, "NPLEx is a proven tool for law enforcement officers and pharmacists in the fight against methamphetamine and continues to block thousands of illegal sales across the country."
About NADDI and Public Safety
Established in 1989, the National Association of Drug Diversion Investigators, Inc. (NADDI) is a unique membership organization whose members are responsible for investigating and prosecuting pharmaceutical drug diversion. The organization has proven to be a valuable asset to law enforcement, the pharmaceutical industry and health regulatory personnel. NADDI's objective is simple: to improve the members' ability to investigate, and prosecute, pharmaceutical drug diversion. You can learn about NADDI here: www.NADDI.org